期刊文献+

Study on the blood-borne virus co-infection and T lymphocyte subset among intravenous drug users 被引量:1

Study on the blood-borne virus co-infection and T lymphocyte subset among intravenous drug users
下载PDF
导出
摘要 AIM: To investigate the features of various blood- borne virus infections and co-infection in intravenous drug users (IDUs), and to examine the correlation of T lymphocyte subsets with virus co-infection. METHODS: Four hundred and six IDUs without any clinical manifestation of hepatitis and 102 healthy persons were enrolled in this study. HBV-DNA and HCV-RNA were detected by fluorescence quantitative PCR. HBsAg, HBeAg, anti-HBc, anti-HCV, HDV-Ag, anti-HGV, anti-HIV, and HCMV-IgM were assayed by enzyme-linked immunosorbent assay (ELISA) and immunochromatographic tests. The levels of Th1 and Th2 cytokines were measured by ELISA and radioactive immune assay (RIA). The T lymphocyte subpopulation was detected by using fluorescence immunoassay. The similar indices taken from the healthy persons served as controls. RESULTS: The viral infection rate among IDUs was 36.45% for HBV, 69.7% for HCV, 47.3% for HIV, 2.22% for HDV, 1.97% for HGV, and 3.45% for HCMV. The co- infection rate of blood-borne virus was detected in 255 of 406 (62.81%) IDUs. More than 80% (161/192) of subjects infected with HIV were co-infected with the other viruses, such as HBV, HCV. In contrast, among the controls, the infection rate was 17.65% for HBV and 0% for the other viruses. Our investigation showed that there was a profound decrease in the proportion of CD4/CD8 and the percentage of CD3 and CD4, but not in the percentage of CD8. The levels of PHA-induced cytokines (IFN-γ and IL-4) and serum IL-2 were obviously decreased in IDUs. On the other hand, the level of serum IL-4 was increased. The level of IFN-γ and the percentage of CD4 were continuously decreased when the IDUs were infected with HIV or HIV co-infection. IDUs with HIV and HBV co-infection was 15.1% (29/192). Of those 29 IDU with HIV and HBV co-infection, 51.72% (15/29) and 37.93% (11/29) were HBV-DNA-positive and HBeAg-positive, respectively. But, among IDUs without HIV infection, only 1.68% (2/119) of cases were HBV- DNA-positive.CONCLUSION: HCV, HBV and HIV infections are common in this population of IDU, leading to a high incidence of impaired Thl cytokine levels and CD4 lymphocyte. IDUs with HIV and HBV/HCV co-infection have lower expression of Th1 cytokine with enhancement of the Th2 response. HIV may be causing HBV replication by decreasing Thl function. AIM: To investigate the features of various blood- borne virus infections and co-infection in intravenous drug users (IDUs), and to examine the correlation of T lymphocyte subsets with virus co-infection. METHODS: Four hundred and six IDUs without any clinical manifestation of hepatitis and 102 healthy persons were enrolled in this study. HBV-DNA and HCV-RNA were detected by fluorescence quantitative PCR. HBsAg, HBeAg, anti-HBc, anti-HCV, HDV-Ag, anti-HGV, anti-HIV, and HCMV-IgM were assayed by enzyme-linked immunosorbent assay (ELISA) and immunochromatographic tests. The levels of Th1 and Th2 cytokines were measured by ELISA and radioactive immune assay (RIA). The T lymphocyte subpopulation was detected by using fluorescence immunoassay. The similar indices taken from the healthy persons served as controls. RESULTS: The viral infection rate among IDUs was 36.45% for HBV, 69.7% for HCV, 47.3% for HIV, 2.22% for HDV, 1.97% for HGV, and 3.45% for HCMV. The co- infection rate of blood-borne virus was detected in 255 of 406 (62.81%) IDUs. More than 80% (161/192) of subjects infected with HIV were co-infected with the other viruses, such as HBV, HCV. In contrast, among the controls, the infection rate was 17.65% for HBV and 0% for the other viruses. Our investigation showed that there was a profound decrease in the proportion of CD4/CD8 and the percentage of CD3 and CD4, but not in the percentage of CD8. The levels of PHA-induced cytokines (IFN-γ and IL-4) and serum IL-2 were obviously decreased in IDUs. On the other hand, the level ofserum IL-4 was increased. The level of IFN-γ and the percentage of CD4 were continuously decreased when the IDUs were infected with HIV or HIV co-infection. IDUs with HIV and HBV co-infection was 15.1% (29/192). Of those 29 IDU with HIV and HBV co-infection, 51.72% (15/29) and 37.93% (11/29) were HBV-DNA-positive and HBeAg-positive, respectively. But, among IDUs without HIV infection, only 1.68% (2/119) of cases were HBV- DNA-positive. CONCLUSION: HCV, HBV and HIV infections are common in this population of IDU, leading to a high incidence of impaired Th1 cytokine levels and CD4 lymphocyte. IDUs with HIV and HBV/HCV co-infection have lower expression of Th1 cytokine with enhancement of the Th2 response. HIV may be causing HBV replication by decreasing Th1 function.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2007年第16期2357-2362,共6页 世界胃肠病学杂志(英文版)
基金 Supported by the National Natural Sciences Foundation of China, No. 30160083
关键词 Intravenous drug users T lymphocyte subpopulation Blood-borne virus CO-INFECTION CYTOKINE 静脉注射吸毒者 血液传播病毒 联合感染 T淋巴细胞亚群
  • 相关文献

参考文献2

二级参考文献28

  • 1[1]Kumarasamy N,Vallabhaneni S,Flanigan TP,Mayer KH,Solomon S.Clinical profile of HIV in India.Indian J Med Res 2005; 121:377-394
  • 2[2]Rathi PM,Amarapurkar DN,Borges NE,Koppikar GV,Kalro RH.Spectrum of liver diseases in HIV infection.Indian J Gastroenterol 1997; 16:94-95
  • 3[3]2006 Report on the Global AIDS Epidemic.Available from:http://www.unaids.org/en/HIV_data/2006GlobalReport/default.asp Accessed on 2.6.2006
  • 4[4]Alter MJ.Epidemiology of viral hepatitis and HIV co-infection.J Hepato12006; 44:S6-S9
  • 5[5]Rockstroh JK.Management of hepatitis B and C in HIV coinfected patients.J Acquir Immune Defic Syndr 2003; 34 Suppl 1:S59-S65
  • 6[6]Dodig M,Tavill AS.Hepatitis C and human immunodeficiency virus coinfections.J Clin Gastroenterol 2001; 33:367-374
  • 7[7]Tien PC.Management and treatment of hepatitis C virus infection in HIV-infected adults:recommendations from the Veterans Affairs Hepatitis C Resource Center Program and National Hepatitis C Program Office.Am J Gastroenterol 2005;100:2338-2354
  • 8[8]Sungkanuparph S,Vibhagool A,Manosuthi W,Kiertiburanakul S,Atamasirikul K,Aumkhyan A,Thakkinstian A.Prevalence of hepatitis B virus and hepatitis C virus co-infection with human immunodeficiency virus in Thai patients:a tertiary-care-based study.J Med Assoc Thai 2004; 87:1349-1354
  • 9[9]Kumarasamy N,Solomon S,Flanigan TP,Hemalatha R,Thyagarajan SP,Mayer KH.Natural history of human immunodeficiency virus disease in southern India.Clin Infect Dis 2003; 36:79-85
  • 10[10]Sud A,Singh J,Dhiman RK,Wanchu A,Singh S,Chawla Y.Hepatitis B virus co-infection in HIV infected patients.Trop Gastroenterol 2001; 22:90-92

共引文献16

同被引文献11

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部